Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.
Showing 181–200 of 1,000 recalls
GlaxoSmithKline LLC
Failed Release Testing: Coarse Particle Mass for umeclidinium Out of Specification
Azurity Pharmaceuticals, Inc.
Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months.